Aesthetic Competitors

Stocks . USA . 
Stock . Aesthetic Medical International
PAIYY Stock   0.06  0.00  0.00%   
Aesthetic Medical competes with Encision, and Zelira Therapeutics; as well as few others. The company classifies itself under Life Sciences Tools & Services sector and is part of Health Care industry. Analyzing Aesthetic Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aesthetic Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Aesthetic Medical Correlation with its peers.

Aesthetic Medical vs Livewire Ergogenics Correlation

Average diversification

The correlation between Aesthetic Medical Internationa and LVVV is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aesthetic Medical Internationa and LVVV in the same portfolio, assuming nothing else is changed.

Moving against Aesthetic Stock

  0.79FIBK First Interstate Ban Normal TradingPairCorr
  0.69FTRE Fortrea HoldingsPairCorr
  0.68SLF Sun Life Financial Earnings Call This WeekPairCorr
  0.68YLLXF Yellow Cake plcPairCorr
  0.67ENS Enersys Earnings Call This WeekPairCorr
Return On Tangible Assets is likely to drop to -0.04 in 2026. Return On Capital Employed is likely to drop to -0.05 in 2026. At this time, Aesthetic Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 417.8 M in 2026, whereas Non Currrent Assets Other are likely to drop slightly above 30.3 M in 2026.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aesthetic Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0826.40
Details
Intrinsic
Valuation
LowRealHigh
0.000.0626.38
Details
Naive
Forecast
LowNextHigh
0.00070.0426.35
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.110.20
Details

Aesthetic Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aesthetic Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Aesthetic and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aesthetic Medical does not affect the price movement of the other competitor.

High positive correlations

ZLDAF
+ 0.57
PLLWF
PLLWF
+ 0.55
BNVIF
ZLDAF
+ 0.55
BNVIF
RHEP
+ 0.43
ECIA
LVVV
+ 0.32
PKTX
PKTX
+ 0.08
BNVIF
  

High negative correlations

LVVV
- 0.43
RHEP
ZLDAF
- 0.4
ECIA
RHEP
- 0.3
PKTX
LVVV
- 0.29
PLLWF
PLLWF
- 0.29
ECIA
NRPR
- 0.27
ECIA

Risk-Adjusted Indicators

There is a big difference between Aesthetic Stock performing well and Aesthetic Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aesthetic Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ECIA  7.75  1.13  0.05  1.43  9.53 
(33.17)
 26.67 
(20.00)
 111.05 
BNVIF  23.90  11.80  0.00 (2.53) 0.00 
 0.00 
 0.00 
 0.00 
 844.44 
PLLWF  33.36  14.96  0.00 (2.49) 0.00 
 0.00 
 0.00 
 0.00 
 644.63 
RQHTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
NRPR  3.24  0.05  0.00  0.09  0.00 
 0.00 
 0.00 
 0.00 
 129.28 
RDDTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ZLDAF  2.56  1.25  0.00 (1.37) 0.00 
 0.00 
 0.00 
 0.00 
 55.56 
PKTX  8.90  0.73  0.03 (0.65) 12.97 
(12.40)
 27.45 
(22.22)
 88.90 
RHEP  3.24  0.29  0.04 (2.34) 4.05 
(4.40)
 9.49 
(8.76)
 30.85 
LVVV  10.47  0.57  0.03  0.37  12.31 
(27.33)
 33.33 
(25.00)
 91.67 

Aesthetic Medical Competitive Analysis

The better you understand Aesthetic Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aesthetic Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aesthetic Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PAIYY ECIA BNVIF PLLWF RQHTF NRPR ZLDAF PKTX RHEP LVVV
 0.00 
 0.06 
Aesthetic
 35.71 
 0.19 
Encision
 0.00 
 0.0005 
Binovi
 0.00 
 0.01 
Polarean
 0.00 
 0.01 
Reliq
 0.00 
 0.02 
Nutri
 55.56 
 0.42 
Zelira
 47.47 
 0.01 
Protokinetix
 0.74 
 1.37 
Regional
 16.67 
 0.0007 
Livewire
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Out of control
Very steady
Out of control
Out of control
Out of control
Extremely Dangerous
Out of control
Market Performance
(90 Days Performance)
Mild
Fair
Fair
Good
Weakest
Weak
Good
Soft
Soft
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Strong
Low
Low
Average
High
High
Low
Fair
Unknown
Small
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
3.26
0.57
10.43
4.61
0.72
3.12
0.54
N/A
0.96
Net Asset
486.22 M
5.66 M
12.3 M
34.53 M
10.27 M
N/A
37.7 M
446.23 K
N/A
N/A
Profit Margin
-0.0108
-0.0887
N/A
N/A
-0.39
-0.39
N/A
N/A
N/A
N/A
EBITDA
73.33 M
760.82 K
(8.2 M)
(13.38 M)
(8.02 M)
(423.34 K)
(11.77 M)
(2.33 M)
N/A
(2.26 M)
Operating Margin
0.0118
-0.0876
-15.09
-11.27
-0.45
-0.38
-8.57
N/A
N/A
-4.27
Current Valuation
27.19 M
6.09 M
576.69 K
114.3 M
78.18 M
67.46 K
4.97 M
7.5 M
N/A
12.65 M
Price To Book
0.86
1.99
0.0771
4.81
16.65
N/A
0.29
20.13
N/A
N/A
Retained Earnings
(1.2 B)
(23.79 M)
N/A
N/A
N/A
N/A
N/A
(28.25 M)
N/A
(8.67 M)
Current Asset
N/A
2.6 M
N/A
N/A
N/A
N/A
N/A
180 K
N/A
171 K
Beta
0.28
0.35
0.39
0.67
1.52
-1.87
1.35
0.13
N/A
0.66
Number Of Employees
1.31 K
31
5
28
13
4
11
7
N/A
1
Shares Outstanding
48.69 M
11.76 M
26.61 M
213.05 M
196.76 M
938.62 K
9.58 M
316.85 M
N/A
1.19 B
Cash Flow From Operations
79.67 M
219.95 K
(6.07 M)
(12.25 M)
(8.03 M)
22.68 K
(9.43 M)
(889.89 K)
N/A
356.16 K
Total Debt
179.3 M
206 K
34.43 K
430.26 K
40 K
125.86 K
500.91 K
N/A
N/A
2.86 M
Return On Equity
-2.04
-0.22
-0.72
-0.49
-0.65
N/A
-0.34
-4.03
N/A
-14.83
Z Score
N/A
8.6
28.8
N/A
N/A
N/A
9.0
N/A
N/A
N/A
Return On Asset
0.022
-0.0831
-0.31
-0.27
-0.29
N/A
-0.21
-2.22
N/A
-0.3
Number Of Shares Shorted
294.37 K
3.19 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
0.0672
0.22
0.59
0.12
0.043
0.044
3.68
0.001
N/A
N/A
Current Liabilities
N/A
1.18 M
N/A
N/A
N/A
N/A
N/A
40 K
N/A
1.09 M
Total Asset
486.22 M
5.66 M
12.3 M
34.53 M
10.27 M
N/A
37.7 M
446.23 K
N/A
176 K
Short Ratio
0.48
0.49
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt To Equity
N/A
0.35
0.11
0.016
0.047
0.53
0.014
31.5
N/A
4.05
Target Price
N/A
N/A
N/A
1.0
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
8.2
N/A
32.42
0.01
N/A
N/A
0.022
N/A
N/A
Market Capitalization
2.78 M
4.7 M
1.65 M
125.73 M
73.78 M
30.22 K
7.98 M
9.51 M
N/A
12.65 M
Price To Earning
N/A
16.67
N/A
N/A
-7.07
0.07
20.0
-9.86
N/A
N/A
Price To Sales
0.0037
0.75
3.86
97.91
6.99
0.0263
4.37
N/A
N/A
22.13
Net Income
(1.35 M)
584.73 K
(9.03 M)
(14.02 M)
(8.17 M)
(467.59 K)
(11.95 M)
(2.33 M)
N/A
(1.6 M)
Earnings Per Share
-0.02
0.01
-0.39
-0.071
-0.039
-0.65
-1.05
-0.009
N/A
-0.002
Shares Owned By Insiders
N/A
45.79
5.93
25.95
1.76
N/A
44.26
30.73
N/A
N/A
Revenue
755.67 M
7.54 M
728.48 K
1.19 M
8.55 M
1.21 M
1.54 M
N/A
N/A
571.68 K
Working Capital
(313.96 M)
1.42 M
N/A
N/A
N/A
N/A
N/A
140 K
N/A
(917 K)
Cash And Equivalents
N/A
827.94 K
1.02 M
22.69 M
890.15 K
90.07 K
2.75 M
18.83 K
N/A
164.77 K
Cash Per Share
N/A
0.07
0.04
0.11
N/A
0.09
0.29
N/A
N/A
N/A
Gross Profit
327.95 M
3.79 M
440.89 K
508.02 K
5.3 M
18.95 K
601.57 K
N/A
N/A
540.32 K
Day Typical Price
0.06
0.19
5.0E-4
0.0066
0.01
0.02
0.42
0.0052
1.35
6.0E-4
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0511
0.29
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.07
2.0E-4
Daily Balance Of Power
0.0
9.2 T
0.0
0.0
0.0
0.0
9.2 T
0
0.1429
0.5
Period Momentum Indicator
N/A
0.05
N/A
N/A
N/A
N/A
0.15
(0)
0.01
1.0E-4
Rate Of Daily Change
1.0
1.36
1.0
1.0
1.0
1.0
1.56
0.53
1.01
1.17
Day Median Price
0.06
0.19
5.0E-4
0.0066
0.01
0.02
0.42
0.0052
1.34
6.0E-4
Price Action Indicator
N/A
0.025
N/A
N/A
N/A
N/A
0.075
(0)
0.04
1.0E-4
Coefficient Of Variation
1771.81
1419.1
862.25
681.2
N/A
4039.42
621.42
2174.39
1674.39
2453.15
Mean Deviation
11.66
7.75
23.9
33.36
N/A
3.24
2.56
8.9
3.24
10.47
Jensen Alpha
2.09
1.13
11.8
14.96
N/A
0.0465
1.25
0.734
0.2933
0.5704
Total Risk Alpha
(1.09)
(0.50)
1.68
4.73
N/A
(0.95)
0.4494
(0.77)
(0.20)
(1.06)
Sortino Ratio
0.0335
0.0464
N/A
N/A
N/A
N/A
N/A
0.0288
0.0375
0.0272
Downside Variance
1618.83
583.04
N/A
N/A
N/A
N/A
N/A
397.15
29.6
565.78
Standard Deviation
25.47
17.16
98.71
98.84
N/A
12.62
7.4
14.42
4.92
18.09
Kurtosis
8.32
12.21
65.58
29.35
N/A
29.09
46.5
2.93
2.88
3.15
Potential Upside
52.17
26.67
N/A
N/A
N/A
N/A
N/A
27.45
9.49
33.33
Treynor Ratio
(0.17)
1.43
(2.53)
(2.49)
N/A
0.0942
(1.37)
(0.65)
(2.34)
0.3693
Maximum Drawdown
183.08
111.05
844.44
644.63
N/A
129.28
55.56
88.9
30.85
91.67
Variance
648.54
294.49
9743.47
9770.2
N/A
159.18
54.82
208.08
24.17
327.16
Market Risk Adjusted Performance
(0.16)
1.44
(2.52)
(2.48)
N/A
0.1042
(1.36)
(0.64)
(2.33)
0.3793
Risk Adjusted Performance
0.0552
0.0663
0.1034
0.1282
N/A
0.0293
0.1386
0.0465
0.0565
0.0424
Skewness
1.74
2.19
8.08
5.46
N/A
3.22
6.53
(0.31)
0.4229
0.8861
Semi Deviation
15.16
9.53
N/A
N/A
N/A
N/A
N/A
12.97
4.05
12.31
Information Ratio
0.0529
0.0652
0.1151
0.1459
N/A
0.0176
0.1488
0.0398
0.0415
0.0358
Value At Risk
(44.29)
(20.00)
N/A
N/A
N/A
N/A
N/A
(22.22)
(8.76)
(25.00)
Expected Short fall
(44.18)
(33.17)
N/A
N/A
N/A
N/A
N/A
(12.40)
(4.40)
(27.33)
Downside Deviation
40.23
24.15
N/A
N/A
N/A
N/A
N/A
19.93
5.44
23.79
Semi Variance
229.8
90.83
N/A
N/A
N/A
N/A
N/A
168.11
16.4
151.57

Aesthetic Medical Competition Performance Charts

Five steps to successful analysis of Aesthetic Medical Competition

Aesthetic Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aesthetic Medical in relation to its competition. Aesthetic Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Aesthetic Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aesthetic Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aesthetic Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Aesthetic Medical position

In addition to having Aesthetic Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Aesthetic Stock Analysis

When running Aesthetic Medical's price analysis, check to measure Aesthetic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aesthetic Medical is operating at the current time. Most of Aesthetic Medical's value examination focuses on studying past and present price action to predict the probability of Aesthetic Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aesthetic Medical's price. Additionally, you may evaluate how the addition of Aesthetic Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY